Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Kalvista Pharmaceuticals Inc. (KALV)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Vivo Capital

Albert Cha And Frank Kung

1,476,796 $17,869 1.28%
2.
Ikarian Capital

Neil Shahrestani

1,113,395 $13,472 +18% 1.07%
3.
Logos Capital

Arsani William

562,900 $6,811 1.36%
4.
Opaleye Management

James A. Silverman

461,500 $5,584 +106% 1.12%
5.
Adage Capital Management

Phill Gross And Robert Atchinson

400,000 $4,840 0.01%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$11.87 7,962 Director 10,000 2019-09-27 Filing
$11.90 2,038 Director 2,038 2019-09-26 Filing
$17.13 5,137 Director 124,566 2019-07-29 Filing
$17.13 24,730 Director 1,022,493 2019-07-29 Filing
$16.83 21,942 Director 997,763 2019-07-26 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$17.10 100 Officer 82,869 2020-02-05 Filing
$17.11 100 Officer 96,634 2020-02-05 Filing
$17.05 200 Officer, Director 238,220 2020-02-05 Filing
$17.02 2,646 Officer 82,969 2019-12-20 Filing
$17.02 2,300 Officer, Director 238,420 2019-12-20 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 1,763,856 $21,342 0%
2. 1,719,576 $20,806 14.43%
3. 1,680,000 $20,328 0.44%
4. 1,148 $13,891 0%
5. 923,851 $11,179 0%
News See All